[EN] MTH1 INHIBITORS FOR TREATMENT OF INFLAMMATORY AND AUTOIMMUNE CONDITIONS [FR] INHIBITEURS DE MTH1 DESTINÉS AU TRAITEMENT DES ÉTATS INFLAMMATOIRES ET AUTO-IMMUNS
[EN] PYRIMIDINE-2,4-DIAMINE DERIVATIVES FOR TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE PYRIMIDINE-2,4-DIAMINE UTILISABLES EN VUE DU TRAITEMENT DU CANCER
申请人:THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING
公开号:WO2014084778A1
公开(公告)日:2014-06-05
A compound of formula (I), or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer or other diseases that may benefit from inhibition of MTH1.
Direct synthesis of 5- and 6-substituted 2-aminopyrimidines as potential non-natural nucleobase analogues
作者:K. Radhakrishnan、Namita Sharma、Lal Mohan Kundu
DOI:10.1039/c4ra00249k
日期:——
A series of 2-aminopyrimidine derivatives, substituted at 5- and 6-positions, were synthesized. The reaction was carried out in a single step by treatment of the corresponding β-ketoester or β-aldehydoester with guanidine hydrochloride in the presence of K2CO3, in a microwave-assisted method without the requirement of solvent. A unique 1 : 1 co-crystal structure was obtained which shows that a 6-p
合成了一系列5-和6-位取代的2-氨基嘧啶衍生物。该反应通过在K 2 CO 3存在下用盐酸胍处理相应的β-酮酸酯或β-醛二酸酯来一步进行。,不需要溶剂的微波辅助方法。获得独特的1:1共晶体结构,其显示6-苯基-2-氨基嘧啶酮与胞嘧啶形成强的核碱基对,涉及三个氢键。发现该碱基对与天然鸟嘌呤:胞嘧啶(G:C)一样强,表明合成衍生物的潜在应用。此外,我们还报告了第二个共晶体,该晶体以5:1的比例包含5-异丙基-6-甲基-2-氨基嘧啶酮和胞嘧啶,这也显示出很强的碱基配对特性。
Pyrimidine-2,4-Diamine Derivatives for Treatment of Cancer
申请人:THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING
公开号:US20160002175A1
公开(公告)日:2016-01-07
A compound of formula (I), or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer or other diseases that may benefit from inhibition of MTH1.
MTH1 inhibitors for treatment of inflammatory and autoimmune conditions
申请人:THOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING
公开号:US10064869B2
公开(公告)日:2018-09-04
A compound of formula (I), or a pharmaceutically acceptable salt thereof, for use in the treatment of autoimmune diseases and inflammatory conditions.
用于治疗自身免疫性疾病和炎症的式 (I) 化合物或其药学上可接受的盐。
Pyrimidine-2,4-diamine derivatives for treatment of cancer
申请人:THOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING
公开号:US10174029B2
公开(公告)日:2019-01-08
A compound of formula I,
or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer or other diseases that may benefit from inhibition of MTH1.
式 I 的化合物、
或其药学上可接受的盐。该化合物可用于治疗癌症或其他可从抑制 MTH1 中获益的疾病。